Patent Assignment
Reel/Frame 060087/0089
Merger
Recorded: 2022-06-02
Pages: 4
Assignor
ALTOR BIOSCIENCE CORPORATION
Executed: 2017-07-31
Assignee
ALTOR ACQUISITION LLC
9920 JEFFERSON BLVD., CULVER CITY, CALIFORNIA, 90232
Covered Property
(1)
Nogapendekin Alfa-Inbakicept For Immune Stimulant Therapies And Treatment Of Viral Infections
Application:
17/594,940 →
Publication:
US 2022/0218789
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the the Name of the Assignee Previously Recorded at Reel: 060087 Frame: 0089. Assignor(S) Hereby Confirms the Assignment.
Jun 7, 2022
From: ALTOR BIOSCIENCE CORPORATION
To: ALTOR BIOSCIENCE, LLC
Reel/Frame 060301/0453 →
Assignment of Assignor's Interest
Aug 4, 2022
From: LEE, JOHN
To: NANTKWEST, INC.
Reel/Frame 060724/0819 →
Assignment of Assignor's Interest
Aug 4, 2022
From: NANTKWEST, INC.
To: ALTOR BIOSCIENCE CORP.
Reel/Frame 060725/0044 →
Assignment of Assignor's Interest
Aug 4, 2022
From: SOON-SHIONG, PATRICK
To: NANT HOLDINGS IP, LLC
Reel/Frame 060725/0086 →
Assignment of Assignor's Interest
Aug 4, 2022
From: RABIZADEH, SHAHROOZ
To: NANTBIO, INC.
Reel/Frame 060725/0119 →
Security Interest
Jan 2, 2024
From: IMMUNITYBIO, INC.; NANTCELL, INC.; RECEPTOME, INC.; VBC HOLDINGS LLC
To: INFINITY SA LLC, AS PURCHASER AGENT
Reel/Frame 066179/0074 →